Ameliorative effects of yokukansan on behavioral deficits in a gerbil model of global cerebral ischemia

Brain Research

Volumn 1543, Issue , 2014, Pages 300-307

  Liu, Yanan ^a   Nakamura, Takehiro ^a   Toyoshima, Tetsuhiko ^a   Lu, Feng ^a   Sumitani, Kazunori ^a   Shinomiya, Aya ^a   Keep, Richad F ^b   Yamamoto, Tohru ^a   Tamiya, Takashi ^a   Itano, Toshifumi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Behavior; Cerebral ischemia; Gerbil; Inflammation; Kampo medicine; Oxidative stress; Yokukansan

Indexed keywords

PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; YOKUKANSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR DISORDER; BRAIN INJURY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CHINESE MEDICINE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DNA DAMAGE; DRUG MECHANISM; FOREBRAIN; GERBIL; HIPPOCAMPAL CA1 REGION; HYPERACTIVITY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

GERBILLINAE;

BEHAVIOR; CEREBRAL ISCHEMIA; GERBIL; INFLAMMATION; KAMPO MEDICINE; OXIDATIVE STRESS; YOKUKANSAN;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS INDUCING FACTOR; BRAIN ISCHEMIA; CELL DEATH; DISEASE MODELS, ANIMAL; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GERBILLINAE; IN SITU NICK-END LABELING; MALE; MAZE LEARNING; MENTAL DISORDERS; MOTOR ACTIVITY;

EID: 84891738807     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.11.015     Document Type: Article

References (33)

1. M. Adams, F. Gmünder, and M. Hamburger Plants traditionally used in age related brain disorders - a survey of ethnobotanical literature J. Ethnopharmacol. 113 2007 363 381
2. J.L. Aguilar, P. Rojas, A. Marcelo, A. Plaza, R. Bauer, E. Reininger, C.A. Klaas, and I. Merfort Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae) J. Ethnopharmacol. 81 2002 271 276
3. M. Amano, M. Hasegawa, T. Hasegawa, and T. Nabeshima Characteristics of transient cerebral ischemia-induced deficits on various learning and memory tasks in male Mongolian gerbils Jpn. J. Pharmacol. 63 1993 469 477
4. K.M. Boje, and P.K. Arora Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death Brain Res. 587 1992 250 256
5. A. Diaz-Ruiz, C. Zavala, S. Montes, A. Ortiz-Plata, H. Salgado-Ceballos, S. Orozco-Suarez, C. Nava-Ruiz, I. Pérez-Neri, F. Perez-Severiano, and C. Ríos Antioxidant, antiinflammatory and antiapoptotic effects of dapsone in a model of brain ischemia/reperfusion in rats J. Neurosci. Res. 86 2008 3410 3419
6. X. Gong, and N.J. Sucher Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development Phytomedicine 9 2002 478 484
7. T. Hiratsuka, S. Matsuzaki, S. Miyata, M. Kinoshita, K. Kakehi, S. Nishida, T. Katayama, and M. Tohyama Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response PLoS One 5 2010 e13280
8. Y. Ikarashi, S. Iizuka, S. Imamura, T. Yamaguchi, K. Sekiguchi, H. Kanno, Z. Kawakami, M. Yuzurihara, Y. Kase, and S. Takeda Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats Biol. Pharm. Bull. 32 2009 1701 1709
9. K. Iwasaki, M. Maruyama, N. Tomita, K. Furukawa, M. Nemoto, H. Fujiwara, T. Seki, M. Fujii, M. Kodama, and H. Arai Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies J. Clin. Psychiatry 66 2005 1612 1613
10. K. Iwasaki, T. Satoh-Nakagawa, M. Maruyama, Y. Monma, M. Nemoto, N. Tomita, H. Tanji, H. Fujiwara, T. Seki, M. Fujii, H. Arai, and H. Sasaki A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients J. Clin. Psychiatry 66 2005 248 252
11. K. Iwasaki, K. Takasaki, A. Nogami, K. Kubota, S. Katsurabayashi, K. Mishima, and M. Fujiwara Pharmacological studies for the ameliorative effects of yokukansan on memory deficits and abnormal behavior in an animal model of dementia Folia Pharmacol. Jpn. 140 2012 66 70
12. R. Jin, G. Yang, and G. Li Inflammatory mechanisms in ischemic stroke: role of inflammatory cells J. Leukoc. Biol. 87 2010 779 789
13. H. Kanno, Z. Kawakami, S. Iizuka, M. Tabuchi, K. Mizoguchi, Y. Ikarashi, and Y. Kase Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid β oligomer-induced neuronal death J. Ethnopharmacol. 149 2013 360 370
14. Z. Kawakami, H. Kanno, T. Ueki, K. Terawaki, M. Tabuchi, Y. Ikarashi, and Y. Kase Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells Neuroscience 159 2009 1397 1407
15. Z. Kawakami, H. Kanno, Y. Ikarashi, and Y. Kase Yokukansan, a kampo medicine, protects against glutamate cytotoxicity due to oxidative stress in PC12 cells J. Ethnopharmacol. 134 2011 74 81
16. P.K. Liu, C.Y. Hsu, M. Dizdaroglu, R.A. Floyd, Y.W. Kow, A. Karakaya, L.E. Rabow, and J.K. Cui Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion J. Neurosci. 16 1996 6795 6806
17. F. Lu, T. Nakamura, T. Toyoshima, Y. Liu, K. Hirooka, N. Kawai, N. Okabe, F. Shiraga, T. Tamiya, O. Miyamoto, R.F. Keep, and T. Itano Edaravone, a free radical scavenger, attenuates behavioral deficits following transient forebrain ischemia by inhibiting oxidative damage in gerbils Neurosci. Lett. 506 2012 28 32
18. C.G. Markgraf, E.J. Green, B.E. Hurwitz, E. Morikawa, W.D. Dietrich, P.M. McCabe, M.D. Ginsberg, and N. Schneiderman Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats Brain Res. 575 1992 238 246
19. Y. Matsuda, T. Kishi, H. Shibayama, and N. Iwata Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials Hum. Psychopharmacol. 28 2013 80 86
20. O. Miyamoto, K. Tamae, H. Kasai, H. Hirakawa, Y. Hayashida, R. Konishi, and T. Itano Suppression of hyperemia and DNA oxidation by indomethacin in cerebral ischemia Eur. J. Pharmacol. 459 2003 179 186
21. J.T. Moroney, E. Bagiella, D.W. Desmond, M.C. Paik, Y. Stern, and T.K. Tatemichi Risk factors for incident dementia after stroke, role of hypoxic and ischemic disorders Stroke 27 1996 1283 1289
22. K. Nagata, E. Yokoyama, T. Yamazaki, D. Takano, T. Maeda, S. Takahashi, and Y. Terayama Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial Phytomedicine 19 2012 524 528
23. T. Nakamura, Y. Kuroda, S. Yamashita, X. Zhang, O. Miyamoto, T. Tamiya, S. Nagao, G. Xi, R.F. Keep, and T. Itano Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage Stroke 39 2008 463 469
24. T. Nakamura, O. Miyamoto, S. Yamagami, T. Toyoshima, T. Negi, T. Itano, and S. Nagao The chronic cell death with DNA fragmentation after post-ischaemic hypothermia in the gerbil hippocampus Acta Neurochir. (Wien) 141 1999 407 412
25. T. Nakamura, S. Tanaka, K. Hirooka, T. Toyoshima, N. Kawai, T. Tamiya, F. Shiraga, M. Tokuda, R.F. Keep, T. Itano, and O. Miyamoto Anti-oxidative effects of d-allose, a rare sugar, on ischemia-reperfusion damage following focal cerebral ischemia in rat Neurosci. Lett. 487 2011 103 106
26. A. Nishi, T. Yamaguchi, K. Sekiguchi, S. Imamura, M. Tabuchi, H. Kanno, Y. Nakai, K. Hashimoto, Y. Ikarashi, and Y. Kase Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin. A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan Neuroscience 207 2012 124 136
27. A. Nogami, Y. Sakata, N. Uchida, K. Yamaguchi, C. Kawasaki, T. Shindo, K. Kubota, S. Katsurabayashi, K. Takasaki, K. Mishima, R. Nishimura, M. Fujiwara, and K. Iwasaki Effects of yokukansan on anxiety-like behavior in a rat model of cerebrovascular dementia J. Nat. Med. 65 2011 275 281
28. N. Okabe, T. Nakamura, T. Toyoshima, O. Miyamoto, F. Lu, and T. Itano Eicosapentaenoic acid prevents memory impairment after ischemia by inhibiting inflammatory response and oxidative damage J. Stroke Cerebrovasc. Dis. 20 2011 188 195
29. P. Pifarré, J. Prado, M. Giralt, A. Molinero, J. Hidalgo, and A. Garcia Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury J. Neurochem. 112 2010 807 817
30. A. Saito, C.M. Maier, P. Narasimhan, T. Nishi, Y.S. Song, F. Yu, J. Liu, Y.S. Lee, C. Nito, H. Kamada, R.L. Dodd, L.B. Hsieh, B. Hassid, E.E. Kim, M. González, and P.H. Chan Oxidative stress and neuronal death/survival signaling in cerebral ischemia Mol. Neurobiol. 31 2005 105 116
31. M. Tabuchi, T. Yamaguchi, S. Iizuka, S. Imamura, Y. Ikarashi, and Y. Kase Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease J. Ethnopharmacol. 122 2009 157 162
32. N. Uchida, K. Takasaki, Y. Sakata, A. Nogami, H. Oishi, T. Watanabe, T. Shindo, N. Egashira, K. Kubota, S. Katsurabayashi, K. Mishima, M. Fujiwara, R. Nishimura, and K. Iwasaki Cholinergic involvement and synaptic dynamin 1 expression in Yokukansan-mediated improvement of spatial memory in a rat model of early Alzheimer's disease Phytother. Res. 27 2013 966 972
33. Q. Zhao, Y. Murakami, M. Tohda, H. Watanabe, and K. Matsumoto Preventive effect of chotosan, a Kampo medicine, on transient ischemia-induced learning deficit is mediated by stimulation of muscarinic M1 but not nicotinic receptor Biol. Pharm. Bull. 28 2005 1873 1878